About me
Kim Wilkinson, Associate Director of Medical Writing at Alexion's Rare Disease Unit, AstraZeneca, brings over a decade of expertise in clinical regulatory documentation. With a Ph.D. in Immunology and Cell Biology, Kim has leveraged their strong scientific background to excel in the pharmaceutical industry. In their current role, Kim leads medical writing activities across disease areas, spearheading document development for submissions and managing complex clinical regulatory documents. Their leadership in implementing AI strategies and process improvements showcases their commitment to advancing the field of medical writing.
